Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011677 |
---|---|
Receipt number | R000013655 |
Scientific Title | Comparison of efficacy and safety of the secondary treatment with increased fesoterodine and with mirabegron combination with 4mg fesoterodine for those who still have moderate or more overactive bladder symptoms after the initial treatment with 4mg fesoterodine: preliminary study |
Date of disclosure of the study information | 2013/09/17 |
Last modified on | 2022/09/19 08:55:55 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/09/07 12:51:33 | ||
2 | Update | 2013/09/07 12:56:46 | Anticipated trial start date |
|
3 | Update | 2018/09/11 10:02:18 | Name of primary person or sponsor Organization |
|
4 | Update | 2022/09/19 08:55:55 | Last follow-up date |